Hypera (STU:HM6A) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:HM6A Hypera SA STU:HM6A
90 GF Score
Price €3.40
GF Value €5.13
! 4 Warning Signs
View Full Analysis

What is Hypera Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Hypera Valuation Rank Related Terms

STU:HM6A
90GF Score
Hypera SA STU:HM6A
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hypera (STU:HM6A) Overvalued in 2026?

Based on GuruFocus' analysis, Hypera stock appears to be undervalued. The current stock price of €3.40 is trading 33.7% below its estimated GF Value™ of €5.13.

Key valuation signals for STU:HM6A:

  • Valuation Rank:
  • GF Value™: €5.13 vs. price of €3.40 (33.7% below fair value)
  • GF Score™: 90/100 with 4 warning signs

No single metric tells the full story. See the STU:HM6A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hypera Business Description

Other Exchanges HYPMY:USAHYPE3:Brazil
Address Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120
Hypera SA is a specialty and generic drug manufacturing company. The company operates in the prescription medicines, over-the-counter (OTC) medicines, branded generics, and generics, and skincare segments within the retail pharmaceutical market. The company also has a wide sales and distribution structure. The company's product portfolio includes key brands in Gastroenterology, Pain, Sun Protection, Skin Moisture, and Cleansing within the over-the-counter (OTC) and Skincare segments, as well as new products in Cardiology, Central Nervous System, and Respiratory System within the prescription medicines segment.
90GF Score

Get the complete analysis for STU:HM6A

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.40
Price
€5.13
GF Value